croi-2013-pocket-program

Sunday
March 3 Oral Sessions
Session 3 CROI 2013
c Sunday, 2:30-4:30 pm; B313
Session 3–Workshop
Clinical Trials Design
This workshop is designed to address several current issues in HIV
clinical trial design and interpretation. These talks are intended for
a general audience and will explore issues such as how to integrate
data from clinical trials with mathematical models, what you need
to know about adaptive trial designs, and alternatives to randomized
clinical trials. These lectures will use examples from recent HIV
treatment and prevention trials and will include time for Q&A.
CROI registrants may attend the workshop. No pre-registration is
required.
Conveners:
Susan Buchbinder, San Francisco Dept
of Publ Hlth, CA, US
Richard Chaisson, Johns Hopkins Univ
Sch of Med, Baltimore, MD, US
2:35-3:10 pm
11
Adaptive Methods: What You Really Need to
Know
Michael Proschan
Biostatistics Res Branch, NIAID, NIH, Bethesda, MD, US
3:10-3:45 pm
12
Alternatives to Randomized Controlled Trials:
When and How to Use
Caroline Sabin
Univ Coll London, UK
3:45-4:20 pm
13
The Symbiotic Relationship between Trials
and Mathematical Models
Timothy Hallett
Imperial Coll London, UK
2 � 20th Conference on Retroviruses and Opportunistic Infections
f Sunday, 5-7 pm; Hall B1
Session 4–Opening
Greetings from the Program Committee
Kevin De Cock
CDC Kenya, Nairobi
Remarks from the Director of the US Centers
for Disease Control and Prevention
Thomas Frieden
CDC, Atlanta, GA, US
18 th Bernard Fields Lecture
The Bernard Fields lectureship recognizes a scientist whose body of
work has significantly contributed to the understanding of virology
and viral pathogenesis as exemplified by the career of Bernard Fields.
14
ARV Drug Discovery: HIV-1 Integrase
Inhibitors and Beyond
Daria Hazuda
Merck Res Labs, West Point, PA, US
Objectives: This session is directed to clinicians and scientists
interested in ART and novel targets for drug discovery. It is assumed
that participants have a basic understanding of retroviral biology
and are familiar with HIV therapeutics. At the completion of the
session, participants will have a deeper understanding the biology
of integrase and the development of integrase inhibitors as well as
increased knowledge of the drug discovery process as it applies to
future therapeutics.
7 th N’Galy-Mann Lecture
The N’Galy-Mann lectureship was established in 2006 to recognize
an individual researcher or team who has made important and timely
contributions in epidemiology and clinical research as exemplified
by the collaborative careers of Bosenge N’Galy and Jonathan Mann.
15
MTCT: From Epidemic to Elimination
Lynne Mofenson
Natl Inst of Child Hlth and Human Devt, NIH, Rockville, MD, US
Objectives: This session is directed to clinicians and scientists
interested in the evolution of interventions for PMTCT in the US
and globally, and lessons learned. It is assumed that participants are
familiar with mechanisms of MTCT and interventions to prevent it.
At the completion of the session, participants will be knowledgeable
about clinical trials and implementation science related to PMTCT,
lessons learned from the US, and implications globally
Welcome Reception
7-10 pm
Georgia Aquarium
The Georgia Aquarium is a short walk (3 blocks) from the Convention Center.